BDBM50120103 CHEMBL313466::N-(4-(2-chloro-6-methylphenylamino)imidazo[1,5-a]quinoxalin-7-yl)acetamide::N-[4-(2-Chloro-6-methyl-phenylamino)-imidazo[1,5-a]quinoxalin-7-yl]-acetamide

SMILES CC(=O)Nc1ccc2c(c1)nc(Nc1c(C)cccc1Cl)c1cncn21

InChI Key InChIKey=SJTZRBVECURMON-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50120103   

TargetTyrosine-protein kinase Lck(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50120103(N-(4-(2-chloro-6-methylphenylamino)imidazo[1,5-a]q...)
Affinity DataIC50: 11nMAssay Description:50% inhibition of the phosphorylation of an exogenous substrate by human Lck enzyme.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase Lck(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50120103(N-(4-(2-chloro-6-methylphenylamino)imidazo[1,5-a]q...)
Affinity DataIC50: 11nMAssay Description:Evaluated for inhibition of human p56 Lck tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/30/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase Lck(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50120103(N-(4-(2-chloro-6-methylphenylamino)imidazo[1,5-a]q...)
Affinity DataIC50: 11nMAssay Description:Inhibition of LckMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed